ANIMAL-MODELS OF LESCH-NYHAN SYNDROME

被引:40
作者
JINNAH, HA
GAGE, FH
FRIEDMANN, T
机构
[1] UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,CTR MOLEC GENET,M-034,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093
关键词
Adenosine; Animal models; Dopamine; Hypoxanthine-guanine phosphoribosyltransferase; Lesch-Nyhan syndrome; Purines; Self-injurious behavior;
D O I
10.1016/0361-9230(90)90239-V
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In humans, deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) is associated with a disorder known as Lesch-Nyhan syndrome which includes severe neurobehavioral abnormalities. Several animal models which have been developed to examine the neurobiologie substrates of this disorder have suggested a role for abnormal function in purine/dopamine neurotransmission, but the relationship between HPRT-deficiency and these abnormalities remains unknown. Recently, HPRT-deficient mice have been produced which appear to have similar, though more subtle changes in brain dopamine function. These mice will be useful in elucidating the relationship between HPRT-deficiency and the neurological deficits observed in patients with this disorder. © 1990.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 50 条
  • [21] Lesch-Nyhan syndrome: from patient to mouse model
    Kubekina, Marina V.
    Kalmykov, Vladislav A.
    Kusov, Pavel A.
    Silaeva, Yulya Y.
    Deikin, Alexei V.
    JOURNAL OF ANIMAL SCIENCE, 2019, 97 : 46 - 47
  • [22] Clinical utility gene card for: Lesch-Nyhan syndrome
    Torres, Rosa J.
    Puig, Juan G.
    Ceballos-Picot, Irene
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (01) : 2 - 3
  • [23] Lesch-Nyhan syndrome and its variants: examining the behavioral and neurocognitive phenotype
    Harris, James C.
    CURRENT OPINION IN PSYCHIATRY, 2018, 31 (02) : 96 - 102
  • [24] Lesch-Nyhan syndrome:: Reconstruction of a calcaneal defect with a sural flap
    Kesiktas, E
    Gencel, E
    Acartürk, S
    SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 2006, 40 (02): : 117 - 119
  • [25] Levodopa is Not a Useful Treatment for Lesch-Nyhan Disease
    Visser, Jasper E.
    Schretlen, David J.
    Bloem, Bastiaan R.
    Jinnah, Hyder A.
    MOVEMENT DISORDERS, 2011, 26 (04) : 746 - 749
  • [26] ELEVATED FIBRINOPEPTIDE-A (FPA) IN PATIENTS WITH LESCH-NYHAN SYNDROME
    IMAMURA, A
    YAMANOUCHI, H
    KUROKAWA, T
    ARIMA, M
    BRAIN & DEVELOPMENT, 1992, 14 (06) : 424 - 425
  • [27] BACK TO BASICS IN LESCH-NYHAN SYNDROME; THE PARADIGM FOR A BEHAVIOURAL PHENOTYPE
    Harris, J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (09) : 1082 - 1082
  • [28] Dopamine receptor upregulation in Lesch-Nyhan syndrome: A postmortem study
    Saito, Y
    Ito, M
    Hanaoka, S
    Ohama, E
    Akaboshi, S
    Takashima, S
    NEUROPEDIATRICS, 1999, 30 (02) : 66 - 71
  • [29] Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome
    Khue Vu Nguyen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (04) : 1091 - 1095
  • [30] Immunological disorders in a case of patient with Lesch-Nyhan syndrome and pneumonia
    Bartuzi, Zbigniew
    Gawronska-Ukleja, Ewa
    Zbikowska-Gotz, Magdalena
    Slepko, Joanna
    Michalkiewicz, Jacek
    Gackowska, Lidia
    Helmin-Basa, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2006, 11 (03): : 168 - 171